Skip to main content

Methylenedioxymethamphetamine (MDMA)

  • Living reference work entry
  • First Online:
Encyclopedia of Psychopharmacology

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  • Baumann MH, Wang X, Rothman RB (2007) 3, 4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings. Psychopharmacology (Berl) 189:407–424

    Article  CAS  Google Scholar 

  • Bedi G, Phan KL, Angstadt M, de Wit H (2009) Effects of MDMA on sociability and neural response to social threat and social reward. Psychopharmacology (Berl) 207:73–83

    Article  CAS  Google Scholar 

  • de la Torre R, Yubero-Lahoz S, Pardo-Lozano R, Farré M (2012) MDMA, Methamphetamine and CYP2D6 pharmacogenetics: what is clinically relevant? Front Genet 235(3):1–8

    Google Scholar 

  • de Win MM, Jager G, Booij J, Reneman L, Schilt T, Lavini C, Olabarriaga SD, den Heeten GJ, van den Brink W (2008) Sustained effects of ecstasy on the human brain: a prospective neuroimaging study in novel users. Brain 131:2936–2945

    Article  PubMed  Google Scholar 

  • Dumont GJ, Sweep FC, van der Steen R, Hermsen R, Donders AR, Touw DJ, van Gerven JM, Buitelaar JK, Verkes RJ (2009) Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3, 4-methylenedioxymethamphetamine) administration. Soc Neurosci 4:359–366

    Article  CAS  PubMed  Google Scholar 

  • Green AR, Mechan AO, Elliott JM, O’Shea E, Colado MI (2003) The pharmacology and clinical pharmacology of 3, 4-methylenedioxymethamphetamine (MDMA, “ecstasy”). Pharmacol Rev 55:463–508

    Article  CAS  PubMed  Google Scholar 

  • Green AR, Gabrielsson J, Marsden CA, Fone KC (2009) MDMA: on the translation from rodent to human dosing. Psychopharmacology (Berl) 204:375–378

    Article  CAS  Google Scholar 

  • Liechti ME, Vollenweider FX (2001) Which neuroreceptors mediate the subjective effects of MDMA in humans? A summary of mechanistic studies. Hum Psychopharmacol 16:589–598

    Article  CAS  PubMed  Google Scholar 

  • McGregor IS, Callaghan PD, Hunt GE (2008) From ultrasocial to antisocial: a role for oxytocin in the acute reinforcing effects and long-term adverse consequences of drug use? Br J Pharmacol 154:358–368

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Nutt DJ (2009) Equasy – an overlooked addiction with implications for the current debate on drug harms. J Psychopharmacol 23:3–5

    Article  CAS  PubMed  Google Scholar 

  • Pardo-Lozano R, Farré M, Yubero-Lahoz S, O’Mathúna B, Torrens M, Mustata C, Pérez-Mañá C, Langohr K, Cuyàs E, Carbó M, de la Torre R (2012) Clinical pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”): the influence of gender and genetics (CYP2D6, COMT, 5-HTT). PLoS One 7(10):e47599

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Parrott AC (2002) Recreational ecstasy/MDMA, the serotonin syndrome, and serotonergic neurotoxicity. Pharmacol Biochem Behav 71:837–844

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Iain S. McGregor .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this entry

Cite this entry

McGregor, I.S., Callaghan, P.D., Thompson, M.R. (2014). Methylenedioxymethamphetamine (MDMA). In: Stolerman, I., Price, L. (eds) Encyclopedia of Psychopharmacology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-27772-6_154-2

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-27772-6_154-2

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Online ISBN: 978-3-642-27772-6

  • eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences

Publish with us

Policies and ethics